NCT06497829View on ClinicalTrials.gov

Geranylgeraniol Supplementation in Patients With Mevalonate Kinase Deficiency

NARecruitingINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

January 25, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
Mevalonate Kinase Deficiency
Interventions
DIETARY_SUPPLEMENT

geranylgeraniol

GG Pure (Extendlife Natural Products) containing GG gold®30 Annatto Extract, 500 mg capsule, use for 3 months, once daily

Trial Locations (1)

15006

RECRUITING

University Hospital, Motol, Prague

All Listed Sponsors
collaborator

Washington University School of Medicine

OTHER

lead

University Hospital, Motol

OTHER